This site is intended only for healthcare professionals residing in Singapore
Menu
Close
Menu
Close
Non-valvular atrial fibrillation (NVAF) is a common heart arrhythmia, affecting one in 20 people over the age of 65 and one in ten over the age of 751
Explore the latest best practices and resources to help healthcare professionals in the management of NVAF.
Venous thromboembolism (VTE) is a condition in which a blood clot forms2
Explore the latest best practices and resources to help healthcare professionals in the management of VTE.
Improve your understanding of the causes, signs, and symptoms, as well as diagnostic tools and treatment strategies, associated with ATTR-CM.
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
The information provided in this site is intended only for Healthcare Professionals in Singapore. The products discussed herein may have different product labelling in different countries. Pfizer Pte Ltd, Singapore is a subsidiary of Pfizer Inc, a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.
Copyright © 2025 Pfizer Limited. All rights reserved.